Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jan 2025 for Poseida Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Johanna Mylet: trading record in brief
This profile gathers the share dealings of Johanna Mylet in Poseida Therapeutics, Inc., where the filings describe the role as finance chief. We count 9 filings; the first trade dates from 15 January 2021 and the latest from 8 January 2025.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 8 January 2025, reports a transaction in Poseida Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Johanna Mylet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
254,852 sharesCommon StockSEC:0001415889-25-001084:0
80,743 shares0Common StockSEC:0000950170-24-024986:0
92,772 shares0Common StockSEC:0001209191-23-014908:0
50,000 shares0Common StockSEC:0001209191-22-014376:0
2,616 shares@ US$1.173100.0% of flowCommon StockSEC:0001209191-21-070938:0
5 of 5 declarations
